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Abbreviations 
ARRIVE  Animals in Research: Reporting In Vivo Experiments  
NC3Rs  National Centre for the Replacement, Refinement and Reduction of Animals in Research 
In the last decade the number of bioscience journals has increased enormously, with many filling 
specialised niches reflecting new disciplines and technologies. The emergence of open-access journals 
has revolutionised the publication process, maximising the availability of research data. Nevertheless, 
a wealth of evidence shows that across many areas, the reporting of biomedical research is often 
inadequate, leading to the view that even if the science is sound, in many cases the publications 
themselves are not “fit for purpose”, meaning that incomplete reporting of relevant information 
effectively renders many publications of limited value as instruments to inform policy or clinical and 
scientific practice [1–21]. A recent review of clinical research showed that there is considerable 
cumulative waste of financial resources at all stages of the research process, including as a result of 
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publications that are unusable due to poor reporting [22]. It is unlikely that this issue is confined to 
clinical research [2–14,16–20]. 
Failure to describe research methods and to report results appropriately therefore has potential 
scientific, ethical, and economic implications for the entire research process and the reputation of those 
involved in it. This is particularly true for animal research, one of the most controversial areas of 
science. The largest and most comprehensive review of published animal research undertaken to date, 
to our knowledge, has highlighted serious omissions in the way research using animals is reported [5]. 
The survey, commissioned by the National Centre for the Replacement, Refinement and Reduction of 
Animals in Research (NC3Rs), a UK Government-sponsored scientific organisation, found that only 
59% of the 271 randomly chosen articles assessed stated the hypothesis or objective of the study, and 
the number and characteristics of the animals used (i.e., species/strain, sex, and age/weight). Most of 
the papers surveyed did not report using randomisation (87%) or blinding (86%) to reduce bias in 
animal selection and outcome assessment. Only 70% of the publications that used statistical methods 
fully described them and presented the results with a measure of precision or variability [5]. These 
findings are a cause for concern and are consistent with reviews of many research areas, including 
clinical studies, published in recent years [2–22]. 
Good Reporting Is Essential for Peer Review and to Inform Future Research 
Scrutiny by scientific peers has long been the mainstay of “quality control” for the publication 
process. The way that experiments are reported, in terms of the level of detail of methods and the 
presentation of key results, is crucial to the peer review process and, indeed, the subsequent utility and 
validity of the knowledge base that is used to inform future research. The onus is therefore on the 
research community to ensure that their research articles include all relevant information to allow in-
depth critique, and to avoiding duplicating studies and performing redundant experiments. Ideally 
scientific publications should present sufficient information to allow a knowledgeable reader to 
understand what was done, why, and how, and to assess the biological relevance of the study and the 
reliability and validity of the findings. There should also be enough information to allow the 
experiment to be repeated [23]. The problem therefore is how to ensure that all relevant information is 
included in research publications. 
Using Reporting Guidelines Measurably Improves the Quality of Reporting 
Evidence provided by reviews of published research suggests that many researchers and peer 
reviewers would benefit from guidance about what information should be provided in a research 
article. The CONSORT Statement for randomised controlled clinical trials was one of the first 
guidelines developed in response to this need [24,25]. Since publication, an increasing number of 
leading journals have supported CONSORT as part of their instructions to authors [26,27]. As a result, 
convincing evidence is emerging that CONSORT improves the quality and transparency of reports of 
clinical trials [28,29]. 
Following CONSORT, many other guidelines have been developed—there are currently more than 
90 available for reporting different types of health research, most of which have been published in the 
last ten years (see http://www.equator-network.org and references [30,31]). Guidelines have also been Animals 2014, 4 37
 
developed to improve the reporting of other specific bioscience research areas including metabolomics 
and gene expression studies [32–37]. Several organisations support the case for improved reporting 
and recommend the use of reporting guidelines, including the International Committee of Medical 
Journal Editors, the Council of Science Editors, the Committee on Publication Ethics, and the Nuffield 
Council for Bioethics [38–41]. 
Improving the Reporting of Animal Experiments—The ARRIVE Guidelines 
Most bioscience journals currently provide little or no guidance on what information to report when 
describing animal research [42–50]. Our review found that 4% of the 271 journal articles assessed did 
not report the number of animals used anywhere in the methods or the results sections [5]. Reporting 
animal numbers is essential so that the biological and statistical significance of the experimental results 
can be assessed or the data reanalysed, and is also necessary if the experimental methods are to be 
repeated. Improved reporting of these and other details will maximise the availability and utility of the 
information gained from every animal and every experiment, preventing unnecessary animal use in the 
future. To address this, we led an initiative to produce guidelines for reporting animal research. The 
guidelines, referred to as ARRIVE (Animals in Research: Reporting In Vivo Experiments), have been 
developed using the CONSORT Statement as their foundation [24,25]. 
The ARRIVE guidelines consist of a checklist of 20 items describing the minimum information that 
all scientific publications reporting research using animals should include, such as the number and 
specific characteristics of animals used (including species, strain, sex, and genetic background); details 
of housing and husbandry; and the experimental, statistical, and analytical methods (including details 
of methods used to reduce bias such as randomisation and blinding). All the items in the checklist have 
been included to promote high-quality, comprehensive reporting to allow an accurate critical review of 
what was done and what was found. 
Consensus and consultation are the corner-stones of the guideline development process [51]. To 
maximise their utility, the ARRIVE guidelines have been prepared in consultation with scientists, 
statisticians, journal editors, and research funders. We convened an expert working group, comprising 
researchers and statisticians from a range of disciplines, and journal editors from Nature Cell Biology, 
Science, Laboratory Animals, and the British Journal of Pharmacology (see Acknowledgments). At a 
one-day meeting in June 2009, the working group agreed the scope and broad content of a draft set of 
guidelines that were then used as the basis for a wider consultation with the scientific community, 
involving researchers, and grant holders and representatives of the major bioscience funding bodies 
including the Medical Research Council, Wellcome Trust, Biotechnology and Biological Sciences 
Research Council, and The Royal Society (see Table 1). Feedback on the content and wording of the 
items was incorporated into the final version of the checklist. Further feedback on the content utility of 
the guidelines is encouraged and sought. 
The ARRIVE guidelines (see Table 2) can be applied to any area of bioscience research using 
laboratory animals, and the inherent principles apply not only to reporting comparative experiments 
but also to other study designs. Laboratory animal refers to any species of animal undergoing an 
experimental procedure in a research laboratory or formal test setting. The guidelines are not intended 
to be mandatory or absolutely prescriptive, nor to standardise or formalise the structure of reporting. Animals 2014, 4 38
 
Rather they provide a checklist that can be used to guide authors preparing manuscripts for 
publication, and by those involved in peer review for quality assurance, to ensure completeness and 
transparency. 
Improved Reporting Will Maximise the Output of Published Research 
These guidelines were developed to maximise the output from research using animals by optimising 
the information that is provided in publications on the design, conduct, and analysis of the 
experiments. The need for such guidelines is further illustrated by the systematic reviews of animal 
research that have been carried out to assess the efficacy of various drugs and interventions in animal 
models [8,9,13,52–55]. Well-designed and -reported animal studies are the essential building blocks 
from which such a systematic review is constructed. The reviews have found that, in many cases, 
reporting omissions, in addition to the limitations of the animal models used in the individual studies 
assessed in the review, are a barrier to reaching any useful conclusion about the efficacy of the drugs 
and interventions being compared [2,3]. 
Driving improvements in reporting research using animals will require the collective efforts of 
authors, journal editors, peer reviewers, and funding bodies. There is no single simple or rapid 
solution, but the ARRIVE guidelines provide a practical resource to aid these improvements. The 
guidelines will be published in several leading bioscience research journals simultaneously [56–60], 
and publishers have already endorsed the guidelines by including them in their journal Instructions to 
Authors subsequent to publication. The NC3Rs will continue to work with journal editors to extend the 
range of journals adopting the guidelines, and with the scientific community to disseminate the 
guidelines as widely as possible (http://www.nc3rs.org.uk/ARRIVE).  
Table 1. Funding bodies consulted.
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